← Leaderboards
Christopher Y Park
Stanford University
$11,341,558
Attributed
$14,542,767
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,542,767 · 8
By mechanism
R01$13,867,299 · 6
K08$412,371 · 1
R56$263,097 · 1
Top collaborators
- Omar Abdel-Wahab5 shared
- Christopher Edward Mason5 shared
- Jason Mathew Butler1 shared
Most similar at Stanford University
Same institution · by research overlap
- Steven E Coutre$227,396
- Alison Morantz$207,974
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularExhibitsHematopoietic Stem CellsIn VivoGeneticMouse ModelSamplingLeukemiaGenesInsightBaseResistanceTransplantationHematopoiesisPathway InteractionsPathogenesisSelf-RenewalHematopoieticPhenotypeStem CellsProgenitorPlayMalignant Neoplasms
Grant awards (30)
Translating Insights in Follicular Lymphoma for Improved Diagnosis and Classification$714,110
R01 · FY2025 · CA · contact PI
Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1$601,367
R01 · FY2025 · CA · contact PI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$662,916
R01 · FY2024 · CA · contact PI
Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1$571,301
R01 · FY2024 · CA · contact PI
Translational Control of Leukemia Stem Cells - Resubmission - 1$425,616
R01 · FY2024 · CA · contact PI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$685,543
R01 · FY2023 · CA · contact PI
Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1$589,340
R01 · FY2023 · CA · contact PI
Translational Control of Leukemia Stem Cells - Resubmission - 1$439,055
R01 · FY2023 · CA · contact PI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$688,759
R01 · FY2022 · CA · contact PI
Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1$589,340
R01 · FY2022 · CA · contact PI
Translational Control of Leukemia Stem Cells - Resubmission - 1$439,055
R01 · FY2022 · CA · contact PI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$704,849
R01 · FY2021 · CA · contact PI
Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1$637,242
R01 · FY2021 · CA · contact PI
Translational Control of Leukemia Stem Cells - Resubmission - 1$448,015
R01 · FY2021 · CA · contact PI
mTOR Dependent Regulation of Hematopoietic Stem Cell Aging and Longevity$263,097
R56 · FY2021 · AG · contact PI
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes$740,279
R01 · FY2020 · CA · contact PI
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance$536,090
R01 · FY2020 · CA
Translational Control of Leukemia Stem Cells - Resubmission - 1$465,390
R01 · FY2020 · CA · contact PI
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance$520,007
R01 · FY2019 · CA
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance$511,614
R01 · FY2018 · CA
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance$542,767
R01 · FY2017 · CA
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia$351,713
R01 · FY2017 · CA · contact PI
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance$546,497
R01 · FY2016 · CA
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia$366,860
R01 · FY2016 · CA · contact PI
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia$366,860
R01 · FY2015 · CA · contact PI
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia$355,854
R01 · FY2014 · CA · contact PI
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia$366,860
R01 · FY2013 · CA · contact PI
Functional role of microRNA in acute myeloid leukemia stem cells and their normal$137,457
K08 · FY2009 · CA · contact PI
Functional role of microRNA in acute myeloid leukemia stem cells and their normal$137,457
K08 · FY2008 · CA · contact PI
Functional role of microRNA in acute myeloid leukemia stem cells and their normal$137,457
K08 · FY2007 · CA · contact PI